Recombinant streptokinase (Qingdao Guoda)

重组链激酶 （青岛国大生物）

Report date: 2022/01/22 15:19:21

Base Information

Drug NameRecombinant streptokinase (Qingdao Guoda)
Drug Alias Name国大欣通
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaMyocardial Infarction
Original Approved Country/TerritoryMainland China
Original Approved Date2002/10/16
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQingdao Guoda Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQingdao Guoda Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeB01AD01
Related LinksN/A